We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Implanted Heart Sensor Monitors Heart Failure Patients

By HospiMedica International staff writers
Posted on 06 Jul 2015
A tiny, state-of-the-art microchip placed inside the heart remotely monitors vital signs of patients with advanced heart failure (HF). More...


The CardioMEMS HF System is a permanently implantable wireless system that provides pulmonary artery (PA) pressure measurements--including systolic, diastolic, and mean PA pressures--which can then be used by physicians to monitor the status of the patient and, if necessary, initiate changes in medical therapy, with the goal of reducing hospitalizations due to HF. The system consists of three parts: a permanently implanted sensor that utilizes radiofrequency (RF) energy for power; a transvenous catheter delivery system that deploys the sensor within a branch of the left or right distal pulmonary artery (PA); and the CardioMEMS hospital and patient electronics system.

The sensor itself is a resonant circuit consisting of a capacitor and an induction coil. The capacitance of the sensor is a function of the pressure in the sensor's environment, and the resonant frequency is a function of the capacitance. During an RF pulse, the sensor accumulates energy; when excitation stops, the energy is re-radiated by the sensor to the electronics unit. The pressure information is encoded in the frequency of the sensor signal, processed, and transferred to a secure database as an 18 second PA waveform or as a pressure trend data waveform. The CardioMEMS HF System is a product of St. Jude Medical (SJM; St. Paul, MN, USA).

“This new device will enable heart failure patients to live more comfortably, easing their worries as we closely monitor them for the earliest signs of fluid retention, a major cause of the symptoms of breathlessness and tiredness heart failure patients experience,” said Raymond Bietry, MD, assistant professor of cardiology at Mount Sinai Hospital (New York, NY, USA).

The mean PA pressure is typically 9–18 mmHg; pulmonary hypertension is defined as a mean pulmonary artery pressure of greater than 25 mmHg. This may occur as a result of heart problems such as HF, lung or airway diseases such as chronic obstructive pulmonary disease (COPD) or scleroderma, or thromboembolic disease.

Related Links:

St. Jude Medical
Mount Sinai Hospital



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.